DiaSys and VLA Enter Into Agreement in Veterinary Testing

Development of new worm egg counting kits 


WATERBURY, Conn., June 7  /PRNewswire-FirstCall/ -- DiaSys Corporation's (OTC:DYXC) (BULLETIN BOARD: DYXC)  wholly owned subsidiary, DiaSys Europe Limited and the Veterinary Laboratories Agency (VLA), UK, an internationally recognized veterinary research and testing laboratory, have entered into a strategic agreement for the development, validation and commercialization of worm egg counting test kits. As part of the agreement, DiaSys has acquired a license to market the test kits worldwide.

Currently, VLA employs the Improved Modified McMaster Method for worm egg counting, a technique that is considered to be the 'Gold Standard'. It is used routinely for worm egg counts in sheep, goats, deer, cattle, pigs, horses and other exotic species for both research projects and diagnostic samples.

The new DiaSys/VLA Veterinary Helminth Egg Counting Kit is being developed to replace the current technology and incorporates a filter assembly that is self-contained and disposable. This will eliminate both aerosol and contamination problems and will enable a quicker processing time leading to a more economic test. Validation of the new kit will be for compatibility with the Improved Modified McMaster Method using helminth eggs recovered from sheep and cattle maintained at VLA.

"We are very excited about the partnership with the VLA. The collaboration will create new applications for our Parasep technology and VLA's worldwide reputation as a leader in animal health will assist our product development into the growing market of veterinary testing" said Morris Silverman, DiaSys' Chairman.

VLA's Chief Executive, Steve Edwards, said, "We are very pleased to be teaming up with the DiaSys Corporation to develop new parasitological testing kits. The combination of VLA's expertise in this area and the commitment of DiaSys to develop innovative, practical solutions to animal health diagnostics should ensure a successful partnership."

As all major livestock species of economic importance, including companion animals are exposed to challenge from a broad range of parasites, the development of new diagnostic kits will contribute to improving animal health. It is estimated that the losses inflicted on producers at a global level runs into billions of dollars.

About DiaSys:

DiaSys Corporation designs, develops, manufactures and distributes proprietary medical laboratory equipment, consumables and infectious disease test-kits to healthcare & veterinary laboratories worldwide. Headquartered in Waterbury, Connecticut USA, the Company operates in Europe through its wholly owned subsidiary based in Wokingham, England and through distributors in South America. DiaSys, Parasep and Urisep are registered trademarks of DiaSys Corporation.

  Further information about DiaSys can be found at http://www.diasys.com/.

  About VLA:


VLA is an Executive Agency of the Department for Environment Food and Rural Affairs (Defra) and is a regional network of 16 laboratories. The Agency is one of the largest research and diagnostic testing facilities of its kind in the world and is internationally recognized as a centre of scientific excellence. It has close international links with research institutes, universities and commercial companies and acts as an International Reference Laboratory for a wide range of infectious and non-infectious diseases in farm animals. Its aim is to safeguard public and animal health through world-class research and surveillance of farmed livestock.

More information on VLA can be found at http://www.vla.gov.uk/

This press release contains forward-looking statements within the meaning of, and made pursuant to, the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or events, or timing of events, relating to the Company to materially differ from those expressed or implied by such forward looking statements. DiaSys refers interested parties to its most recent Annual Report on Form 10-KSB and other SEC filings for a complete description of, and discussions about, the Company. 

DATASOURCE: DiaSys Corporation



CONTACT:  Jeffrey Aaronson, President of DiaSys Corporation,

[phone]; or Steve Edwards, Chief Executive of Veterinary Laboratories

Agency, VLA, [phone]



Web site:  http://www.diasys.com/

http://www.vla.gov.uk/ 

Copyright